People of Color

How Do We Disrupt the Incredible Burden of COVID-19’s Impact on Communities of Color?

By M. Isabelle Chaudry | Jul 6, 2020 | Comments Off on How Do We Disrupt the Incredible Burden of COVID-19’s Impact on Communities of Color?

Long-standing systemic inequalities including racism and inadequate access to care have led to unconscionable health disparities during the pandemic.

Congressional Hearing — The Disproportionate Impact of COVID-19 on Communities of Color

By M. Isabelle Chaudry | Jun 17, 2020 | Comments Off on Congressional Hearing — The Disproportionate Impact of COVID-19 on Communities of Color

Statement from M. Isabelle Chaudry, Esq., Senior Policy Manager, National Women’s Health Network: House Ways and Means Committee

What Do Racial Health Disparities Look Like During the COVID-19 Pandemic?

By NWHN Staff | Jun 11, 2020 | Comments Off on What Do Racial Health Disparities Look Like During the COVID-19 Pandemic?

According to the CDC, the disproportionate burden of coronavirus felt by communities of color can be attributed to numerous structural factors. Such factors include, but are not limited to: working conditions for essential workers, a lack of paid sick leave, and uninsurance. About a quarter of the Latinx and Black populations in the United States are employed in the service industry, compared to 16% of the White population.

Rx for Change: Skin Lightening

By NWHN Staff | Feb 26, 2020 | Comments Off on Rx for Change: Skin Lightening

Skin lightening — also called skin whitening or skin bleaching — is the practice of using cosmetics to either reduce the appearance of age spots and/or discoloration or to change one’s natural complexion.[1] Skin lightening cosmetics include bleaching creams, soaps, and pills that contain compounds designed to inhibit melanin production and thereby lighten skin.[2]

Model Minority Mutiny

By NWHN Staff | May 31, 2018 | Comments Off on Model Minority Mutiny

Throughout my life, there has been an expectation of perfection. Grades, tests, careers, relationships; everyone expected it all to meet a certain standard. I had fallen victim to the model minority myth.

FDA Meeting – Clinical Trial Diversity

By Sarah Christopherson | Feb 29, 2016 | Comments Off on FDA Meeting – Clinical Trial Diversity

Food and Drug Administration Safety and Innovation Act 907 Public Meeting: Progress on Enhancing the Collection, Analysis, and Availability of Demographic Subgroup Data

Women’s Health: Unequal for Too Long

By NWHN Staff | Sep 1, 2014 | Comments Off on Women’s Health: Unequal for Too Long

Communities of color continue to face substantial cultural, social, and economic barriers to obtaining quality health care and achieving equitable health outcomes. Many of these racial and ethnic health disparities disproportionately impact women.